Susquehanna International Group’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$273K Buy
87,848
+12,246
+16% +$38.1K ﹤0.01% 5163
2025
Q1
$256K Buy
75,602
+13,903
+23% +$47K ﹤0.01% 5234
2024
Q4
$350K Buy
61,699
+28,086
+84% +$159K ﹤0.01% 4557
2024
Q3
$197K Sell
33,613
-23,153
-41% -$135K ﹤0.01% 4823
2024
Q2
$449K Buy
56,766
+20,821
+58% +$165K ﹤0.01% 3666
2024
Q1
$335K Sell
35,945
-11,214
-24% -$104K ﹤0.01% 4041
2023
Q4
$398K Sell
47,159
-2,988
-6% -$25.2K ﹤0.01% 4161
2023
Q3
$389K Sell
50,147
-16,719
-25% -$130K ﹤0.01% 3744
2023
Q2
$766K Sell
66,866
-254,917
-79% -$2.92M ﹤0.01% 3069
2023
Q1
$2.48M Buy
321,783
+182,684
+131% +$1.41M ﹤0.01% 1734
2022
Q4
$849K Buy
139,099
+71,323
+105% +$435K ﹤0.01% 2516
2022
Q3
$401K Sell
67,776
-28,177
-29% -$167K ﹤0.01% 3840
2022
Q2
$567K Buy
+95,953
New +$567K ﹤0.01% 3196
2022
Q1
Sell
-39,992
Closed -$108K 6592
2021
Q4
$108K Buy
39,992
+16,324
+69% +$44.1K ﹤0.01% 5262
2021
Q3
$62K Sell
23,668
-77,929
-77% -$204K ﹤0.01% 5064
2021
Q2
$420K Buy
101,597
+55,301
+119% +$229K ﹤0.01% 4088
2021
Q1
$218K Buy
46,296
+8,558
+23% +$40.3K ﹤0.01% 4698
2020
Q4
$270K Buy
37,738
+16,356
+76% +$117K ﹤0.01% 4000
2020
Q3
$228K Sell
21,382
-551
-3% -$5.88K ﹤0.01% 3802
2020
Q2
$277K Sell
21,933
-16,710
-43% -$211K ﹤0.01% 3448
2020
Q1
$354K Buy
38,643
+25,095
+185% +$230K ﹤0.01% 3260
2019
Q4
$189K Sell
13,548
-4,052
-23% -$56.5K ﹤0.01% 3527
2019
Q3
$303K Sell
17,600
-8,597
-33% -$148K ﹤0.01% 3399
2019
Q2
$713K Buy
+26,197
New +$713K ﹤0.01% 2498
2019
Q1
Sell
-13,607
Closed -$128K 4618
2018
Q4
$128K Buy
+13,607
New +$128K ﹤0.01% 3121
2018
Q3
Hold
0
4782
2018
Q2
Hold
0
4800
2018
Q1
Sell
-36,276
Closed -$602K 4601
2017
Q4
$602K Sell
36,276
-6,921
-16% -$115K ﹤0.01% 2242
2017
Q3
$889K Buy
+43,197
New +$889K ﹤0.01% 1744
2017
Q1
Sell
-18,705
Closed -$238K 4462
2016
Q4
$238K Buy
+18,705
New +$238K ﹤0.01% 3600